Endocrinology / diabetes clinical trials recruiting in Florida

415 recruiting endocrinology / diabetes trials match in Florida. Showing 20.

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting

  Phase 3 · Hoffmann-La Roche · Jacksonville, Florida

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Atlantis, Florida

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting

  Phase 2 · Immunovant Sciences GmbH · Clearwater, Florida

• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Recruiting

  Phase 2 · Sparrow Pharmaceuticals · Edgewater, Florida

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGRecruiting

  Phase 2 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Gainesville, Florida

• Pharmacist-Led Continuous Glucose Monitoring for PrediabetesRecruiting

  N/A · University of South Florida · Tampa, Florida

• Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM MetricsRecruiting

  N/A · Milton S. Hershey Medical Center · Gainesville, Florida

• Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic SteatosisRecruiting

  N/A · AdventHealth Translational Research Institute · Orlando, Florida

• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruiting

  N/A · Natera, Inc. · Jacksonville, Florida

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Recruiting

  Phase 3 · NRG Oncology · Altamonte Springs, Florida

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruiting

  Phase 1 · IDEAYA Biosciences · Coral Springs, Florida

• Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaRecruiting

  Phase 3 · SWOG Cancer Research Network · Tampa, Florida

• SPYRAL GEMINI Pilot StudyRecruiting

  N/A · Medtronic Vascular · Orlando, Florida

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesRecruiting

  Phase 3 · Sanofi · Gainesville, Florida

• BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursRecruiting

  Phase 1 / Phase 2 · Bold Therapeutics, Inc. · Edmonton, Alberta

• A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise HealthyRecruiting

  Phase 1 · Eli Lilly and Company · Daytona Beach, Florida

• A Study of MRG007 (ARR-217) in Patients With Advanced Solid TumorsRecruiting

  Phase 1 · ArriVent BioPharma, Inc. · Sarasota, Florida

• SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesRecruiting

  Phase 2 · SAb Biotherapeutics, Inc. · Gainesville, Florida

• The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With ObesityRecruiting

  Phase 4 · Mayo Clinic · Jacksonville, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.